MiNK Therapeutics, Inc. (INKT) Operating cash flow 2020–2025
MiNK Therapeutics, Inc. (INKT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.9MFY2025 · since FY2020: -$8.3M → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.9M | +38.0% |
| FY2024 | -$9.6M | +39.4% |
| FY2023 | -$15.8M | +16.5% |
| FY2022 | -$18.9M | -47.1% |
| FY2021 | -$12.8M | -53.8% |
| FY2020 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice